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Abstract
Efficient membrane fusion has been successfully mimicked in vitro using artificial membranes and a number of cellular proteins
that are currently known to participate in membrane fusion. However, these proteins are not sufficient to promote efficient
fusion between biological membranes, indicating that critical fusogenic factors remain unidentified.We have recently identified a
TIP30 protein complex containing TIP30, acyl-CoA synthetase long-chain family member 4 (ACSL4) and Endophilin B1 (Endo B1)
that promotes the fusion of endocytic vesicles with Rab5a vesicles, which transport endosomal acidification enzymes vacuolar
(H
+)-ATPases (V-ATPases) to the early endosomes in vivo. Here, we demonstrate that the TIP30 protein complex facilitates the
fusion of endocytic vesicles withRab5a vesicles in vitro. Fusion of the two vesicles also dependson arachidonic acid,coenzyme A
and the synthesis of arachidonyl-CoA by ACSL4. Moreover, the TIP30 complex is able to transfer arachidonyl groups onto
phosphatidic acid (PA), producing a new lipid species that is capable of inducing close contact between membranes. Together,
our data suggest that the TIP30 complex facilitates biological membrane fusion through modification of PA on membranes.
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Introduction
Membrane fusion is well known as one of the most fundamental
cellular processes in living organisms. It generally requires cellular
factors to bring donor and recipient membranes into close pro-
ximity, increase membrane curvature, and disturb lipid bilayers
[1,2]. Extensive studies during the past decades have led to the
identification of a number of fusogenic proteins and lipids. In
addition to lipids such as acyl-CoA [3,4], arachidonic acid [5,6],
phosphoinositides, phosphotidic acid and diacylglycerol [7,8,9],
many proteins including Rab5, Rab5 effectors, SNARE proteins
and SNARE accessory factors are necessary for various mem-
brane fusion events [10,11].
Recently, efficient endosome fusion was successfully mimicked
using proteoliposomes reconstituted with 17 recombinant core
fusion proteins [2,12]. Notably, however, these proteins are not
sufficientto promoteefficientfusion between biological membranes,
indicating that biological membrane fusion requires more cellular
factors than artificial membrane fusion. Given that purified endo-
somes contain the core SNARE proteins Syntaxin6, Syntaxin13,
Vti1a and VAMP4, it is likely that factors needed for initiating
membrane fusion have yet been identified.
Among the lipids that play key roles in membrane fusion,
arachidonicacidhas beenshown toberequiredforendosomefusion
in vitro [6], and is the most effective fusogen in chromaffin granule
fusion [13]. In addition, membrane-bound arachidonic acid can
drive annexin II-mediated membrane fusion of the lamellar body
with the plasma membrane during the exocytosis [5].
We have recently identified a protein complex containing TIP30,
ACSL4 and Endo B1 that interacts with Rab5a and facilitates the
loading of V-ATPases on endocytics vesicles. Inhibiting any of these
proteins causes the mislocalization of V-ATPases, thus leading to the
trapping of EGF-EGFR complexes in endocytic vesicles, delayed
EGFR degradation and sustained EGFR endosomal signaling [14].
In addition, we have shown that Rab5a and V-ATPase reside in
vesicles devoid of EGFR, the early endosomal marker EEA1 and the
recycling endosomal marker transferrin receptor (TfR), suggesting
that Rab5a functions as a identity tag for vesicles that deliver V-
ATPases to endosomes [14]. Given that localization of integral mem-
brane proteins to their target membranes requires vesicle membrane
fusion [15], we therefore examined if the TIP30 protein complex can
promote vesicle membrane fusion in vitro. Since ACSL4 was identified
in the protein complex and it is an acyl-CoA synthetase that prefers
arachidonic acid as the reaction substrate, we included both arachi-
donic acid and coenzyme A in the in vitro membrane fusion reactions.
We found that the TIP30 complex and the synthesis of arachidonyl-
CoA from arachidonic acid and coenzyme A are required for efficient
fusion of Rab5a vesicles with endocytic vesicles. The TIP30 complex
may initiate membrane fusion by modifying membrane PA.
Results
The TIP30 complex, arachidonic acid and coenzyme A
promote fusion between endocytic and Rab5a vesicles
To investigate whether the TIP30 complex can promote mem-
brane fusion in vitro, we used a confocal microscopy-based in vitro
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Rab5a vesicles in an initial pilot experiment. Endocytic and Rab5a
vesicles were prepared from HepG2 cells that do not contain
detectable endogenous TIP30 and EGFR. Rab5a vesicles were
labeled by expressing EYFP-Rab5a fusion proteins and prepared
from serum-starved cells. Endocytic vesicles were labeled by ex-
pressing EGFR-DsRed fusion proteins and prepared from EGF
treated cells. The two types of vesicles that contain equal amount of
proteins were incubated in the fusion buffer at 37uC followed by
examination with confocal microscopy. Vesicle fusion and aggre-
gation were represented by the fluorescence overlap between
EGFR-DsRed and EYFP-Rab5a.
Since ACSL4 is an acyl-CoA ligase with high substrate pre-
ference for arachidonic acid (C20:4) [18], we first tested if arachi-
donic acid and coenzyme A are needed. Vesicles resulting from
reactions that were kept on ice were evenly distributed on the
slides, appearing as small vesicles with low fluorescence intensity
and no fluorescence overlap (Figure 1A, lane 1; Figure 1B). Simi-
larly, no fluorescence overlap was observed in the absence of
arachidonic acid or in the presence of triacsin C (10 uM), a potent
inhibitor of ACSL4 (Figure 1A, lanes 4 and 6; Figure 1B). In
contrast, in the presence of arachidonic acid and coenzyme A,
immunopurified TIP30 complex caused vesicle enlargement and
significantly increased fluorescence overlap (TIP30 complex: 506
6%; control eluates: 2063%; omitting coenzyme A: 176
2%; omitting GTP: 1664%; n=6 representative confocal images
of 1436143 mm, p,0.01 versus TIP30 complex; Figure 1A and
1B), thereby resulting in much intensified fluorescence. Rab5a
vesicles attached to aggregated endocytic vesicles, but remained as
small particles when the TIP30 complex, coenzyme A, or GTP was
omitted. The effect of GTP exclusion is consistent with the fact that
GTP is a known membrane fusion factor and required for Rab5a
function. We next screened for other fatty acids that might
promote membrane fusion, including palmitic, palmitoleic, oleic,
linoleic, linolenic, eicosapentaenoic, and docosahexaenoic acids.
None of these fatty acids could promote vesicle enlargement and
fluorescence overlap (data not shown). Furthermore, arachidonic
acid significantly increased fluorescence overlap in the presence of
HeLa cell cytoplasmic S100 extracts that containing the TIP30
complex (HeLa S100: 262%; HeLa S100+arachidonic acid:
5065%; n=6 representative confocal images of 1436143 mm,
p,0.01 versus HeLa S100; Figure 1C). These results suggest that
arachidonic acid and the TIP30 complex are involved in
membrane aggregation and/or fusion, which are consistent with
our in vivo data [14] and previous reports that arachidonic acid is
essential for vesicle membrane fusion [6,13].
To determine whether that vesicle enlargement and fluores-
cence overlap were due to membrane fusion or aggregation, we
examined the vesicles that resulted from fusion reactions by
transmission electron microscopy (TEM). Without the addition of
arachidonic acid, all vesicles appeared spherical and ranged in
diameter from 50 to 300 nm. In contrast, the complete fusion
reaction led to the production of vesicles enlarged to more than
1 mm in diameter (Figure 2A); the larger vesicles were not found in
reactions without arachidonic acid. Ongoing fusion could also be
observed. Quantitative analysis revealed a significant increase in
the amount of enlarged vesicles (with arachidonic acid: 300–
500 nm, 2462%; .500 nm, 16.561.5%; without arachidonic
acid: 300–500 nm, 160.2%; .500 nm, 0; n=150, p,0.01;
Figure 2B). Given the fluorescent overlap between two types of
vesicles in the complete reactions shown in Figure 1, these results
indicate that the TIP30 complex and synthesis of arachidonyl-
CoA are essential for the fusion of Rab5a vesicles with endocytic
vesicles.
Recombinant TIP30, ACSL4 and Endo B1 can replace the
TIP30 complex in promoting fusion of endocytic vesicles
with Rab5a vesicles
To exclude possible influences of other associated or contam-
inating proteins in immunopurified TIP30 complexes, we replaced
Figure 1. The TIP30 protein complex, arachidonic acid and
coenzyme A promote the fusion between endocytic and Rab5a
vesicles. (A)A l i q u o t so fi s o l a t e dE G F R - D s Red and EYFP-Rab5a vesicles
(both contain 20 mgo fp r o t e i n s )w e r em i x e da n di n c u b a t e di nr e a c t i o n s
(20 ml) with the indicated components. The resulting fusion products were
spotted on glass slides and images were taken using confocal microscope.
Panels 1, 4 and 6 were scanned with 36amplification gain setting due to
lower fluorescence intensity of individual vesicles. Arachidonic acid
(100 nmol) was used in the reactions. Images are single plane and are
representative for at least three independent experiments. Scale bars, 5 mm.
(B) Signal overlap was quantified using MBF_ImageJ. Pearson’s colocaliza-
tion coefficients were calculated from three independent experiments and
were converted to percentages. Data represent means 6 SEM. **P,0.01,
***P,0.001; t test. (C) Arachidonic acid promotes the vesicle fusion induced
by HeLa cell S100. S100 fractions (4 mg/ml) of HeLa cells were incubated
with isolated EGFR-DsRed and EYFP-Rab5a vesicles (both contain 20 mg
proteins) in the absence or presence of 100 nmol arachidonic acid.
Resulting vesicles were examined using confocal microscopy (left panel)
and fluorescence overlaps were quantified (right panel).
doi:10.1371/journal.pone.0021233.g001
The TIP30 Complex Promotes Vesicle Fusion
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21233the immuno-complexes with bacterially-expressed recombinant
TIP30, ACSL4 and Endo B1 in cell free assays. The three highly
purified recombinant proteins (Figure 3A) can efficiently promote
fluorescence overlap (7566%), whereas lack of any of these pro-
teins led to significantly less overlap (TIP30: 1861%; TIP30 and
ACSL4: 2361%; Endo B1: 3563%; ACSL4 and EndoB1: 862%;
ACSL4: 2065%; n=6 representative images of 1436143 mm; p,
0.01 versus TIP30, ACSL4 and Endo B1; Figure 3B and 3C).
TIP30M, a TIP30 mutant with a mutated putative nucleotide
binding motif (GXXGXXG) [19], only promoted 2462% overlap
(n=6representative imagesof1436143 mm;p,0.01versusTIP30,
ACSL4 and Endo B1; Figure 3B and 3C, panel 4). These data sug-
gest that TIP30, ACSL4 and Endo B1 together can substitute for
the TIP30 complex in promoting the fusion between endocytic and
Rab5a vesicles.
Vesicle tethering and stacking induced by acylation of
phosphatidic acid
To gain further insight into how TIP30 and its interacting
proteins mediate membrane fusion, we first used
3H-arachidonic
acid to label membrane lipids and found that at least one lipid
species in purified early endosomes was specifically labeled by the
TIP30 complex (Figure 4A, lane 2). The production of the labeled
lipid was significantly less in the reaction using control eluates (lane
1) or TIP30M immunoprecipitates (lane 3), and was blocked by
triacsin C (lane 5). The new lipid species was not observed when
Rab5a vesicles were used in the reactions (data not shown). These
data indicate that lipids on endocytic vesicles are the specific recip-
ients of the arachidonyl group.
To identify the lipids that are modified, we performed protein-
lipid overlay assays using membrane strips prespotted with 15
cellular membrane lipids (Figure 4B). TIP30 and Endo B1 spe-
cifically bind phosphatidic acid (PA) and cardiolipin. Endo B1 also
binds phosphatidylinositol 4-phosphate (PtdIns(4)P; Figure 4C).
ACSL4 and Rab5a did not bind any lipids spotted on the strips
(data not shown). Cardiolipin is found predominantly in the inner
mitochondrial membrane, whereas PA has been implicated in the
fusion of various intracellular membranes [7,20]. Therefore, we
focused on PA and tested whether the TIP30 complex could con-
vert PA to PA-derivatives. Lipids extracted from the acylation
Figure 2. Transmission electron microscopy analysis of products from in vitro vesicle fusion assays. (A) EGFR-DsRed and EYFP-Rab5a
vesicles were incubated with immunopurified TIP30 complex in the fusion buffer with (right panel) or without (left panel) 100 nmol of arachidonic
acid. Resulting vesicles were stained with uranyl acetate and examined using TEM. Scale bars, 500 nm. (B) The graphs show the percentages of
vesicles with different diameters. At least 6 images from two independent experiments were counted. Data represent means 6 SEM. n=150;
**P,0.01, t test.
doi:10.1371/journal.pone.0021233.g002
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subjected to MS/MS and LC-MS/MS spectrometry analyses
(Figure 5A–5C). The flow injection precursor scan in both modes
revealed one predominant peak with an m/z (mass-to-charge ratio)
value of 940.2, which does not match the exact mass of any known
lipids in the database (lipidmaps.org). Thus, the identity of lipid
productoftheTIP30complexremainsunknown.However,sinceits
mass is very close to the mass (940.85) of triacylglycerols (C61H112O6),
we speculate that it might be a triacylglycerol.
To determine how PA derivatives per se would affect membrane
fusion, we carried out acylation reactions by incubating PA or
phosphoinositide (PI) with the TIP30 complex in the fusion buffer.
The resulting lipids were purified, resuspended by sonication, and
incubated with vesicles. Interestingly, the PA derivatives promoted
dramatic fluorescence overlap among endocytic and Rab5a
vesicles on ice (Figure 6). In contrast, PA incubated with control
eluates did not promote significant fluorescence overlap among the
vesicles, nor did phosphoinositide (PI) that was prepared with the
same procedure as the PA derivative. A triacylglycerol (1,2-
Dilinoleoyl-3-palmitoyl-rac-glycerol) with a palmitoyl tail at the sn-
3 position also increases significant fluorescence overlap (Figure 6).
. These results indicate that the PA derivatives possibly promote
membrane aggregation and/or fusion.
Finally, we used electron microscopy to examine the vesicles
after incubation with PA derivatives that were generated by either
immunopurified or recombinant protein-reconstituted TIP30 com-
plexes (Figure 7). PA derivatives caused vesicle tethering and
stacking, which is marked by dramatic deformation (Figure 7B and
7C). In contrast, the vesicle aggregation caused by triacyglycerol
seemed due only to tethering (Figure 7E), indicating that these
specific commercially available triacyglycerols do not have the
ability to induce vesicle stacking; therefore do not represent the new
lipid species generated by the TIP30 complex. Consistent with the
confocal microscopy data, PA treated with control eluates (Figure 7A)
or PI treated with immunpurified TIP30 complex (Figure 7D) had no
apparent effect.
Nonetheless, we did not observe complete fluorescence overlap
and enlarged endosomes (.0.5 mm in diameter) as seen in Figure 2,
suggesting that additional activities of the TIP30 complex or other
proteins on the membranes, such as SNAREs, SNARE accessory
factors, Rab5a and its effectors, are needed to accomplish the fusion
steps following close membrane contact. Collectively, these data
indicate that TIP30, ACSL4, and Endo B1 promote vesicle mem-
brane fusion by fatty acylating PA.
Discussion
Elucidating the molecular basis of intracellular trafficking and
protein sorting requires the identification of the critical compo-
nents participating in these processes. Our earlier studies demon-
strated that proteins in the TIP30 protein complex are required for
the fusion of endocytic and Rab5a vesicles in vivo. In the present
study, using both confocal microscopy and transmission electron
microscopy, we demonstrated that the TIP30 complex promotes
membrane fusion in vitro and that arachidonyl-CoA synthesis by
ACSL4, a component in the TIP30 complex, is essential for
membrane fusion.
Arachidonic acid has been shown to be involved in vesicle
membrane fusion [6,13]. Previous reconstituted approaches in vitro
have contributed greatly to our understanding of membrane fusion.
However, to our knowledge, efficient fusion between biological
membranes has hardly been achieved in vitro in cell free assays
without using cytosol fractions or arachidonic acid, further empha-
sizing the important role of arachidonic acid during membrane
fusion. How does arachidonic acid promote membrane fusion?
Arachidonic acid has been proposed to stimulate SNARE complex
assembly [21,22,23]. Our data seem support these observations by
showing that endocytic vesicles recognize Rab5a vesicles only after
arachidonic acid was added to the reactions. Interestingly, fusion
did not occur in the absence of the TIP30 complex or in the
presence of the ACSL4 inhibitor. These results suggest that in addi-
tion to directly promoting SNARE complex assembly, arachidonic
acid must be activated by esterification to stimulate membrane
fusion.
We further showed that the arachidonyl group is transferred to
endosomal PA to generate a new lipid species that induce vesicle
tethering and stacking. Thus, we suggest a hypothesis that arachi-
donic acid promotes membrane fusion by contributing to both PA
Figure 3. Bacterially expressed recombinant TIP30, ACSL4 and
Endo B1 can replace the TIP30 complex in promoting efficient
vesicle fusion. (A) Recombinant proteins were expressed in BL21 cells
and were purified using cobalt affinity resins. Eluted proteins were
subjected to SDS-PAGE analysis followed by Coomassie blue staining.
Images were acquired using a Li-Cor scanner. (B) EGFR-DsRed and EYFP-
Rab5a vesicles were incubated with the indicated recombinant proteins
(20 ng each) in the fusion buffer. Resulting fusion products were
examined using confocal microscope. Scale bars, 5 mm. (C) Quantifica-
tion of images represented in (B). Signal overlap was quantified using
MBF_ImageJ. Pearson’s colocalization coefficients were calculated from
three independent experiments and converted to percentages. Data
represent means 6 SEM. **P,0.01, ***P,0.001; t test.
doi:10.1371/journal.pone.0021233.g003
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view, PA and its synthetase phospholipase D (PLD) are known to
participate in membrane fusion during vesicle transport [20,24].
Moreover, as integral components of many biological membranes,
triacylglycerols have been demonstrated to possess great potency
to promote spontaneous curvature in an acyl chain length de-
pendent manner [25], which may alter membrane structure to
support membrane fusion [1,2]. We speculate that the addition of
the hydrophobic acyl chain to endosomal PA may help to over-
come the repulsive hydration force generated from water bound to
the lipid headgroups. In addition, triacylglycerols can exhibit an
extended conformation [26] with the 3-arachidonyl group in the
opposite direction of the other two acyl chains, thereby allowing
for attachment and fusion between two membranes [27,28]. Our
results suggest that as an initiation event, acylation of endosomal
PA enables the close contact between donor and recipient mem-
branes, thus allowing for fusion to be accomplished by SNAREs,
SNARE accessory factors, Rab5 and its effectors. Nevertheless,
although we favor this hypothesis to explain the role of TIP30 in
membrane fusion and endocytic trafficking, we do not rule out
other possible hypotheses that may also explain the actions of the
TIP30 complex. Undoubtedly, efficient fusion could be achieved
using artificial membranes in the absence of arachidonic acid. This
may be due to the fact that artificial membranes are far less
complex than biological membranes in terms of membrane
composition, organization and dynamics, thereby requiring much
less factors to fuse. This view is supported by the observation that
the same set of proteins could promote efficient fusion of artificial
membranes but incapable of inducing efficient biological mem-
brane fusion [12]. Furthermore, our data suggest that the TIP30
complex modifies lipids to initiate membrane fusion. This step
may have been bypassed during the processes of lipid extraction
and membrane reconstitution. It would be interesting to find out
whether addition of arachidonic acid, CoA and the TIP30
complex could enhance artificial membrane fusion.
Clearly, more work is needed to determine how fatty acylated
PA and other lipid derivatives cooperate with the action of
SNAREs, Rab5 and their effectors in membrane fusion. Future
studies may also focus on finding out how the TIP30 complex
acylates PA and what the exact identity of the fusion products is. It
is expected that a more precise mechanism underlying membrane
fusion will emerge by integrating information from studies of both
lipids and proteins.
Materials and Methods
Reagents
DMEM, fetal bovine serum, trypsin, penicillin, and streptomy-
cin were purchased from Invitrogen. Anti-HA agarose beads were
from Roche Applied Science. Polyclonal rabbit anti-human Rab5a
Figure 4. TIP30 and Endo B1 strongly bind phosphatidic acid. (A) Fatty acylation of endosomal lipids by the TIP30 complex. [
3H]-arachidonic
acid can be transferred to endosomal membrane lipids by the TIP30 complex, but not by TIP30M immunoprecipitates or control immunoprecipitates
(left panel). The transfer was blocked by 10 mM triacsin C (right panel). Image was acquired by scanning lipids resolved on TLC plate with a Molecular
Dynamics Storm 860. * indicates the radiolabeled lipid. (B) The schematic diagram shows the lipid species pre-spotted on membranes that are used
in lipid-protein overlay assays. (C) TIP30 and Endo B1 strongly bind phosphatidic acid (PA). Protein-lipid overlay assays were carried out by incubating
recombinant proteins with membrane strips containing 15 pre-spotted lipids. Membranes were scanned using a Li-Cor scanner after being
sequentially overlaid with primary and fluorescent secondary antibodies.
doi:10.1371/journal.pone.0021233.g004
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buffer. Resulting lipids were purified and subjected to flow injection negative scan in the range of 400–1400 u. A predominant peak of 699.5 was
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ACSL4 was a generous gift from Stephen Prescott (University of
Utah). Polyclonal rabbit anti-human Endo B1, LPA, triacylgly-
cerol (1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol), arachidonic acid
and CoA were from Sigma-Aldrich. PA (1,2-dioleoyl-sn-glycero-3-
phosphate) were purchased from Avanti Polar Lipids. [
3H]-
arachidonic acid was from PerkinElmer.
Cell culture
PLC/PRF/5 and HepG2 cell lines were purchased from ATCC
and cultured in DMEM supplemented with 10% fetal bovine
serum and penicillin/streptomycin at 37uCi n5 %C O 2.
Immunoprecipitation
Immunoprecipitations were performed as previously described [14].
Purification of endocytic and Rab5a vesicles
HepG2 cells were transduced by the lentivirus carrying vector
pSin-EGFR-DsRed or pSin-EYFP-Rab5a and were selected for 4
days with 2 mg/ml puromycin. To prepare endosomes carrying
EGFR-DsRed, we treated cells with 10 ng/ml EGF at 37uC for
10 minutes and purified early endosomes on the flotation gradient
essentially as described [29]. Briefly, cells were incubated with
10 ng/ml EGF for 10 min at 37uC. After several washings, cells
were scraped and pelleted at 4uC before being subjected to needle
breakdown in homogenization buffer (250 mM sucrose, 3 mM
imidazole, pH 7.4, 1 mM EDTA) at 4uC. Homogenates were
centrifuged at 3000 rpm for 10 min at 4uC and post-nuclear
supernatants (PNS) were collected. PNSs were then suspended in
40.6% sucrose by adding a stock solution (62% sucrose, 3 mM
imidazole, pH 7.4, 1 mM EDTA) and loaded at the bottom of a
SW40 centrifugation tube. The load was then sequentially overlaid
with 1.5 ml of 35% sucrose in 3 mM imidazole, pH 7.4 with
1 mM EDTA; 1 ml of 25% sucrose in 3 mM imidazole, pH 7.4
with 1 mM EDTA; and at the top with 0.5 ml of homogenization
buffer. The gradient was centrifuged at 125000 g for 60 min at
4uC. Early endosomal fractions were collected at the 35%/25%
sucrose interface.
Rab5 vesicles containing EYFP-Rab5a were prepared as de-
scribed [30]. Briefly, HepG2 cells expressing pSin-EYFP-Rab5a
were starved for 24 hours before being scraped and pelleted at
4uC. PNSs were prepared as described above. PNSs were then
centrifuged at 10000 rpm at 4uC using a bench top centrifuge. The
post mitochondria supernatants were loaded on top of homogeni-
zation buffer in SW40 centrifugation tubes with 0.5 ml cushion
solution (62% sucrose, 3 mM imidazole, pH 7.4, 1 mM EDTA) at
the bottom.Centrifugation was done at 100000 g for 60 min at 4uC
and Rab5a vesicles were collected on top of the cushion solution.
In vitro vesicle fusion assay
The assay was performed as described previously with modi-
fications [16,17]. Briefly, EGFR-DsRED endocytic vesicles and
EYFP-Rab5a vesicles (aliquotes of both contain 20 mg proteins)
were gently mixed in a total volume of 20 ml fusion buffer (10 mM
Hepes, pH 7.4, 1.5 mM MgOAc, 1 mM DTT, 50 mM KOAc,
100 nmol arachidonic acid, 1 mM coenzyme A, 5 mM GTP,
complemented with 4 ml of an ATP-regenerating system contain-
ing 1:1:1 mixture of 100 mM ATP, 600 mM creatine phosphate,
and 4 mg/ml creatine phosphokinase). After incubating with
indicated purified proteins at 37uC for 40 min, a portion of the
reactions were spotted on slides and examined using Zeiss LSM
510 Meta confocal microscope. All images are representative
single optical sections. Colocalization analysis was done using
MBF_ImageJ. For reactions in Figure 5, PA and PI were
incubated with control eluates or the TIP30 complex in a total
volume of 200 ml fusion buffer. Resulting lipids were purified using
Bligh-Dyer Method [31] and incubated with vesicles in homog-
enization buffer (250 mM sucrose, 5 mM Hepes, pH 7.4) on ice.
Figure 6. Fatty acylation of phosphatidic acid promotes vesicle aggregation. Lipids were extracted after incubating 100 nmol PA or
phosphatidylinositol (PI) with 100 nmol arachidonic acid the TIP30 complex or control eluates. Lipids were resuspended in homogenization buffer by
sonication and were mixed with EGFR-DsRed and EYFP-Rab5a vesicles in in vitro fusion buffer at 37uC. Resulting vesicles were spotted on glass slides
and images were taken using confocal microscope. Scale bars, 5 mm.
doi:10.1371/journal.pone.0021233.g006
detected. Atomic mass: arachidonic acid, 304.5 u; 18:1 PA, 699.5 u. The lipids in the smaller peaks have molecular weights that do not match any of
the expected PA derivatives. (B) The flow injection negative precursor scan for 303.2 u over a mass range of 400–1400 u. (C) The LC-C18 negative
precursor scan for 303.2 u over a mass range of 400–1400 u. The lipids after the acylation reaction was extracted and chromatographed on a C-18
column to reduce possible adduction mechanisms of compounds detected in the flow injection negative precursor scan of 303.2 u.
doi:10.1371/journal.pone.0021233.g005
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ously using TEM JEOL 100CX [12].
Protein-lipid overlay assays
Protein-lipid overlay assays were performed essentially as
previously described [32]. Briefly, membrane strips (Echelon
Biosciences Inc.) containing 15 pre-spotted lipids were incubated
overnight at 4uC with recombinant proteins (10 mg/ml) in TBST
with 5% milk. After being washed with TBST 10 min each for 3
times, the strips were incubated overnight at 4uC with specific
primary antibodies against the recombinant proteins in TBST with
5% milk. The strips then were washed again and incubated with
corresponding fluorescent secondary antibodies at room tempera-
ture for 1 hour. Images were acquired by scanning the strips using a
Li-Cor scanner.
Lipid acylation
Purified endocytic vesicles (aliquots containing 20 mg proteins)
were incubated with indicated proteins and [
3H]-arachidonic acid
(PerkinElmer) in the presence or absence of 10 mM triacsin C at
37uC for 1 hour in a total volume of 200 ml fusion buffer. Lipids
were extracted using Bligh-Dyer Method [31] and resolved on silica
gel 60 TLC plate with chloroform/ethanol/water/triethylamine
(30/35/7/35) as the solvent. The TLC plate was exposed to Kodak
Tritium Sensitive Storage Phosphor Screen. Images were acquired
by scanning the screen using a Molecular Dynamics Storm 860. For
preparation oflipid derivativesfromPA, PIorLPA,100 nmol lipids
were incubated with immunopurified TIP30 complex or recombi-
nant TIP30, ACSL4 and Endo B1 in the fusion buffer. Resulting
lipids were purified using Bligh-Dyer Method [31].
MS/MS spectrometry analysis
MS/MS spectrometry analysis of PA derivatives were per-
formed in Avanti Polar Lipids Inc. Briefly, PA derivatives were
extracted according to Bligh-Dyer method and redissoved in
methanol/chloroform (85/18) with 10 mM NH4OAC and 1 ug/
ml NH4OH. First, standards of 17:0–20:4 PA and 17:0–20:4 PI
were prepared in the above solution and infused in the API 4000
QTrap triple quadrupole with linear ion trap instrument for opti-
mization of collisional energy to provide mass fragments of
arachidonic acid (20:4) at 303.2 u. Then samples were flow
injected into the MS/MS in negative scan mode to discover
products from the described reaction. The m/z value was used to
search the most likely molecular species at http://www.lipidmaps.
org.
Statistical analysis
All statistical tests were two-tailed t-test. Data represent means
6 SEM. *P,0.05, **P,0.01.
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Figure 7. Fatty acylation of phosphatidic acid induce vesicle tethering and stacking. Effects of acylated PA on vesicle fusion were
determined using electron microscope. Lipids were extracted after incubating PA with control immunoprecipitates (A), PA with immunopurified
TIP30 complex (B), PA with recombinant TIP30, ACSL4, and Endo B1 (C) or PI with immunopurified TIP30 complex (D). Each of these lipids or
triacylglycerol (E) was suspended in homogenization buffer and incubated on ice with EGFR-DsRed and EYFP-Rab5a vesicles. The resulting vesicles
were examined using TEM. Scale bars, 500 nm.
doi:10.1371/journal.pone.0021233.g007
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